One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2019-124349
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 1 |
Affiliation: National and Kapodistrian University of Athens, Erasmus MC Cancer Institute, Copenhagen University Hospital, Rigshospitalet, Essen University Hospital, Southampton General Hospital, Dana-Farber Cancer Institute, University Medical Center Freiburg, Bristol-Myers Squibb (Switzerland), Hôpital Fleurimont, The University of Texas Southwestern Medical Center, Queen Elizabeth II Health Sciences Centre, Dalhousie University, University Medical Center Hamburg-Eppendorf, Universität Hamburg, Clinica Universidad de Navarra
Pomalidomide + Bortezomib + Low-Dose Dexamethasone after 1 Prior Line of Therapy in Patients with Lenalidomide-Pretreated Multiple Myeloma: Subanalysis of the Phase 3 Optimismm Trial By Patient Age and Prior Stem Cell Transplant
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
